Skip to main content
News Directory 3
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World

Berberine Cognitive Function Diabetic Encephalopathy Mice

September 9, 2025 Jennifer Chen Health
News Context
At a glance
  • Diabetic⁢ encephalopathy (DE) is⁤ a condition marked ⁣by cognitive decline‍ resulting⁤ from chronic high ⁢blood sugar levels.
  • Recent ⁢research highlights the ‌crucial connection between gut health and neurological⁤ function.
  • Researchers at the State⁢ Key Laboratory of Bioactive Substance and⁣ Function​ of Natural Medicines‌ at ⁤the ​Chinese Academy of⁤ Medical⁢ Sciences & Peking Union Medical College conducted ⁢a...
Original source: news-medical.net

“`html

Berberine Shows Promise‍ in Treating Diabetic ‌Encephalopathy

Table of Contents

  • Berberine Shows Promise‍ in Treating Diabetic ‌Encephalopathy
    • What⁣ is Diabetic Encephalopathy?
    • The Role of‍ the ⁤Gut Microbiota
    • Study Details: Berberine’s Impact on Mice
    • Improved Cerebral Vessel⁢ Integrity
    • What is berberine?
      • At a Glance
      • Editor’s Analysis

What⁣ is Diabetic Encephalopathy?

Diabetic⁢ encephalopathy (DE) is⁤ a condition marked ⁣by cognitive decline‍ resulting⁤ from chronic high ⁢blood sugar levels. It significantly increases the risk of⁢ severe neurological disorders,including Alzheimer’s disease. The underlying causes are⁣ complex,⁢ involving cerebrovascular inflammation and ​the activation of inflammatory pathways like Toll-like receptor-4 (TLR-4) and ‍nuclear factor kappa B (NF-κB).

The Role of‍ the ⁤Gut Microbiota

Recent ⁢research highlights the ‌crucial connection between gut health and neurological⁤ function. The gut microbiota-the community of microorganisms living in the digestive ‍tract-influences brain health through various mechanisms. Imbalances in the gut microbiota can exacerbate⁤ inflammation and contribute to ⁤the progress of DE. This study investigates whether berberine (BBR) can modulate ‍the gut microbiota to alleviate the ⁤symptoms⁢ of DE.

Study Details: Berberine’s Impact on Mice

Researchers at the State⁢ Key Laboratory of Bioactive Substance and⁣ Function​ of Natural Medicines‌ at ⁤the ​Chinese Academy of⁤ Medical⁢ Sciences & Peking Union Medical College conducted ⁢a study using a type 2​ diabetic encephalopathy KK-Ay (2DEK) mouse model. The mice were divided ⁢into three groups:

  • Control ⁣Group: Received ⁤no treatment.
  • Low-Dose BBR Group:⁤ Received 100 mg/kg/day of ‌berberine.
  • High-Dose‌ BBR Group: Received ‌200 mg/kg/day of berberine.

After ten weeks of treatment,​ cognitive function was assessed using novel⁢ object recognition and step-down tests. The results demonstrated that BBR treatment significantly ⁢improved cognitive ⁣performance, with the high-dose group showing ‌the most⁤ substantial gains.

Improved Cerebral Vessel⁢ Integrity

high-resolution imaging using fluorescence micro-optical sectioning⁤ tomography (fMOST) revealed that BBR treatment enhanced⁢ the integrity of ‍brain ​vessels. ​ Specifically,the⁣ following improvements were observed:

Vessel Parameter Improvement with BBR⁢ Treatment
Average Vessel⁣ Diameter significantly increased
Vessel Length Density Significantly increased
Total Vessel Volume Significantly ‍increased

What is berberine?

Berberine (BBR) is a natural compound ​found in several plants,traditionally ​used in Chinese medicine. It has demonstrated​ a range of pharmacological‍ effects, including anti-inflammatory, antioxidant, ‍and ⁣antimicrobial⁢ properties.⁤ Its ability ​to modulate the gut‍ microbiota is ⁤a‌ key factor ⁤in its potential therapeutic benefits for DE.

At a Glance

  • What: ⁣Berberine (BBR)‌ shows promise in treating diabetic encephalopathy (DE).
  • Where: Research conducted at the chinese Academy ​of Medical Sciences & Peking Union‍ Medical College.
  • When: Study published recently in Engineering.
  • Why it Matters: DE is a serious complication of diabetes that can ⁣lead‌ to ⁢cognitive impairment and Alzheimer’s disease.
  • What’s Next: Further research is needed‌ to ⁢confirm these findings in human clinical trials.

Editor’s Analysis

This study provides ‍compelling preclinical evidence for⁢ the potential of berberine as a therapeutic agent for​ diabetic encephalopathy. The focus on the ‌gut microbiota is particularly noteworthy,as it aligns with the ‌growing​ understanding of the gut-brain axis. ⁢While these results are promising,​ it’s crucial to remember that they were obtained ⁢in a mouse model. ⁢ Human ‍clinical trials

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Alzheimer's disease, bacteria, Blood, brain, Chronic, Cognitive Function, Compound, Encephalopathy, Hyperglycemia, inflammation, Laboratory, Medicine, Research

Search:

News Directory 3

ByoDirectory is a comprehensive directory of businesses and services across the United States. Find what you need, when you need it.

Quick Links

  • Disclaimer
  • Terms and Conditions
  • About Us
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Editorial Guidelines
  • Privacy Policy

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

Connect With Us

© 2026 News Directory 3. All rights reserved.

Privacy Policy Terms of Service